【ChiCTR2200056204】ONLINE MINDFULNESS THERAPY AS A SMOKING CESSATION AID IN MALAYSIA: A RANDOMIZED CONTROL TRIAL
ChiCTR2200056204
尚未开始
/
/
/
2022-02-01
/
/
Non-communicable diseases
ONLINE MINDFULNESS THERAPY AS A SMOKING CESSATION AID IN MALAYSIA: A RANDOMIZED CONTROL TRIAL
ONLINE MINDFULNESS THERAPY AS A SMOKING CESSATION AID IN MALAYSIA: A RANDOMIZED CONTROL TRIAL
71800
General Objective To determine whether counselling or mindfulness therapy is a better intervention as a quit smoking aid among smokers. Specific Objectives 1. To compare the difference of the scores on Fagerstrom Test for Nicotine Dependence before and after intervention in the two intervention groups using counselling and mindfulness therapy. 2. To compare the difference of the scores on QSU-Brief before and after intervention in the two intervention groups using counselling and mindfulness therapy. 3. To compare the difference of the scores on DASS before and after intervention in the two intervention groups using counselling and mindfulness therapy. 4. To compare the difference of the scores on the mindfulness, attention, and awareness scale (MAAS) before and after intervention in the two intervention groups using counselling and mindfulness therapy. 5. To compare the difference of the scores on AAQ-2 before and after intervention in the two intervention groups using counselling and mindfulness therapy. 6. The compare difference and linear relationship of the number of average cigarettes smoked per day in the two intervention groups using counselling and mindfulness therapy.
随机抽样
Ⅰ期
All the eligible participants who were included into the study after the screening process will be randomized to either mindfulness therapy group or counselling group. The randomization process will completely be done by using computer generated randomization Excel software to excluded bias.
The intervention group will be labelled Group A for mindfulness therapy and Group B for counselling therapy, hence the participate only will be told which group they are assigned to without informing what kind of therapy they are subjected to undergo.
University Malaysia Sabah, Malaysia
/
79
/
2022-01-01
2023-10-01
/
1. Adult aged 18 to 60 years; 2. Smokers who are moderately dependent or highly dependent according to the Fagerstrom test; 3. Able to understand Malay and English moderately; 4. Have excess to the internet connection; 5. Currently residing in Malaysia.;
请登录查看1. Currently undergoing any other smoking cessation program which is conducted under private or government healthcare center (Quit smoking clinics); 2. On any kind of nicotine replacement therapy; 3. Currently using any kind of psychoactive medications; 4. Has a serious or unstable medical/mental condition.;
请登录查看University Malaysia Sabah, Malaysia
88400
University Malaysia Sabah, Malaysia的其他临床试验
马来西亚沙巴大学的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
